ISPS ID:
D165
Suggested citation:
Broockman, D., Kalla, J., Guerrero, A., Budolfson, M., Eyal, N., Jewell, N. P., Magalhaes, M., & Sekhon, J. S. (2021). Replication Materials for, “Broad Cross-National Public Support for Accelerated COVID-19 Vaccine Trial Designs.” http://hdl.handle.net/10079/b702aaad-bac7-4b81-b92e-93630cad5e2f. ISPS Data Archive.
Research design:
Field Date:
2020-05
Location:
Location details:
Australia, Canada, Hong Kong, New Zealand, South Africa, Singapore, the United Kingdom, and the United States
Unit of observation:
Individual
Sample size:
5920
Inclusion/exclusion:
Participants were recruited using the online sample provider Lucid
Randomization procedure:
Survey respondents were randomly assigned to participate in one of two studies. Study 1 asked respondents about a standard Phase III trial. Study 2 asked respondents about a standard Phase II followed by Phase III trial and an integrated Phase II and III trial.
Treatment:
N/A
Treatment administration:
Not applicable
Outcome measures:
Prefers Scientists Conduct Challenge Study; How Ethical; How Scientifically Valid; Would Take Vaccine
Archive date:
2021
Terms of use:
ISPS Data Archive: Terms of Use.
Discipline:
Area of study:
